COMMUNIQUÉS West-GlobeNewswire

argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
15/10/2025
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patients Real-world evidence and long-term data reinforce VYVGART’s sustained impact on patient [...]
Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe
15/10/2025
BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received a new CE certificate for its new breast-imaging AI – the only on the market allowed to operate as an independent second reader for both [...]
Voting Rights and Shares Capital of the Company
15/10/2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE [...]
EyePoint Announces Pricing of Public Offering
15/10/2025
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
14/10/2025
GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
14/10/2025
ZUG, Switzerland, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The attached two notifications relate to the exercise of vested stock options to purchase ordinary shares previously granted to a director of the Company, and the [...]
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
14/10/2025
Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
MedCert.us Expands Affordable Licensed Telehealth Medical Marijuana Evaluations Across New York and Virginia
14/10/2025
Licensed medical providers deliver same-day cannabis certifications through secure telehealth consultations for just , ensuring accessible, compliant, and compassionate care under state law. Arlington, Virginia , Oct. [...]
PetMeds® Files Form 10-K for Fiscal 2025
14/10/2025
DELRAY BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange Commission (SEC) its [...]
EyePoint Announces Proposed Public Offering of Common Stock
14/10/2025
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
14/10/2025
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System , a fully comprehensive [...]
Nova Leap Health Corp. to Highlight Record Q2 2025 Results at Planet MicroCap Showcase Toronto
14/10/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review Process
14/10/2025
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a major step forward for obesity solutions, Fuzzle, a pioneering health technology company, announced today that its innovative oral device has officially entered the U.S [...]
EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements
14/10/2025
Defying national trends in downward Medicare Advantage ratings for not-for-profit health plans, EmblemHealth increased its Medicare Star rating for the second consecutive year. NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE [...]
Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management
14/10/2025
Needle-Free Compounded Semaglutide and Tirzepatide Tablets Offer Physician-Supervised, At-Home GLP-1 Treatment Access Through MEDVi’s Nationwide Telehealth Platform Los Angeles, Oct. 14, 2025 (GLOBE NEWSWIRE) -- [...]
Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
14/10/2025
Daix (France), New York City (New York, Etats-Unis), le 14 octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva Announces the Implementation of a New ATM Program
14/10/2025
Daix (France), New York City (New York, United States), October 14, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
14/10/2025
– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data [...]
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
14/10/2025
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune [...]

Pages